Ambient Particulate Air Pollution and Ectopy—The Environmental Epidemiology of Arrhythmogenesis in Women's Health Initiative Study, 1999–2004 by Liao, Duanping et al.
Ambient particulate air pollution and ectopy - The Environmental
Epidemiology of Arrhythmogenesis in Women’s Health Initiative
Study, 1999-2004
Duanping Liao1, Eric A. Whitsel2, Yinkang Duan1, Hung-Mo Lin1, P. Miguel Quibrera2,
Richard Smith3, Donna J. Peuquet4, Ronald J. Prineas5, Zhu-Ming Zhang5, and Garnet
Anderson6
1Pennsylvania State University College of Medicine Department of Public Health Sciences, Hershey, PA
2University of North Carolina, Schools of Public Health and Medicine, Departments of Epidemiology and
Medicine, Chapel Hill, NC
3University of North Carolina, Department of Statistics & Operations Research, Chapel Hill, NC
4Pennsylvania State University, Department of Geography, University Park, PA.
5Wake Forest University Division of Public Health Sciences, EPICARE, Winston-Salem, NC
6Fred Hutchinson Cancer Research Center, Seattle, WA
Abstract
The relationships between ambient PM2.5 and PM10 and arrhythmia and the effect modification by
cigarette smoking were investigated. Data from EPA air quality monitors and an established national-
scale, log-normal kriging method were used to spatially estimate daily mean concentrations of PM
at addresses of 57,422 individuals from 59 examination sites in 24 US states in 1999-2004. The acute
and subacute exposures were estimated as mean, geocoded address-specific PM concentrations on
the day of, 0-2 days before, and averaged over 30 days before the ECG (Lag0; Lag1; Lag2;
Lag1-30). At the time of standard 12-lead resting ECG, the mean age (SD) of participants was 67.5
(6.9) years (84% non-Hispanic White; 6% current smoker; 15% with coronary heart disease; 5%
with ectopy). After the identification of significant effect modifiers, two-stage random-effects models
were used to calculate center-pooled odds ratios and 95% confidence intervals (OR, 95% CI) of
arrhythmia per 10 μg/m3 increase in PM concentrations. Among current smokers, Lag0 and Lag1
PM concentrations were significantly associated ventricular ectopy (VE) - the OR (95% CI) for VE
among current smokers was 2 (1.32-3.3) and 1.32 (1.07-1.65) at Lag1 PM2.5 and PM10, respectively.
The interactions between current smoking and acute exposures (Lag0; Lag1; Lag2) were significant
in relationship to VE. Acute exposures were not significantly associated with supraventricular ectopy
(SVE), or with VE among non-smokers. Subacute (Lag1-30) exposures were not significantly
associated with arrhythmia. Acute PM2.5 and PM10 exposure is directly associated with the odds of
VE among smokers, suggesting that they are more vulnerable to the arrhythmogenic effects of PM.
Introduction
Numerous studies have consistently found a significant association between particulate matter
(PM) air pollution and the risk of cardiovascular disease (Brook et al. 2004; Craig et al.
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2008). The mechanisms responsible for such association, although not fully understood, have
been the focus of recent environmental health studies. Panel and population-based studies alike
(Creason et al. 2001; Gold et al. 2000, Liao et al. 1999, 2004; Pope et al. 1999; Yang et al.
2004) suggested that sympathetic activation and parasympathetic suppression is one of the
underlying mechanisms linking air pollution and increased risk of cardiovascular disease
(CVD). It is biologically plausible that such alteration in cardiac autonomic control may
decrease arrhythmia thresholds and thereby increase the risk of arrhythmia (Huikuri et al.
2001; Ultich et al. 2002). On the other hand, it is also well-documented (Engel et al, 2007;
Rautaharju et al, 2006a) that ventricular ectopy (VE)and supraventricular ectopy (SVE) are
the most frequent forms of arrhythmia in the general population. Ectopy, especially VE, is
associated with a higher risk of incident cardiac events (Engel et al, 2007). However, only a
few, typically small, single-city studies of majority-male, patient populations with implantable
cardioverter-defibrillators (ICD) or Holter ECG have assessed the potential role of ventricular
arrhythmogenesis in PM-mediated cardiovascular risk (Peters et al 2000; Rich et al. 2004;
2005; 2006; Vedal et al. 2004; Dockery et al. 2005a; 2005b; Ebelt et al. 2005; Berger et al.
2006; Sarnat et al. 2006; Metzger et al. 2007).
This study was designed to investigate the relationship between exposures to ambient
particulate matter < 2.5 μm (PM2.5) or <10 μm (PM10) in diameter and VE and SVE as detected
by a resting, standard 12-lead ECG in a relatively large and geographically diverse population
of women enrolled in the Women’s Health Initiative (WHI) clinical trials (WHI CT).
Methods
Population
The research objectives were addressed in The Environmental Epidemiology of
Arrhythmogenesis in WHI (EEAWHI), an ancillary study of proarrhythmic mechanisms
linking air pollution and cardiovascular disease in WHI CT participants. The clinical trials
were designed to allow randomized, controlled evaluation of dietary modification, estrogen or
estrogen plus progesterone, and calcium / vitamin D supplementation on risk of breast and
colorectal cancer, cardiovascular disease, and bone fractures (WHI Study Group. 1998).
Between 1992 and 1998, the trials enrolled 68,133 postmenopausal women aged 50 to 79 years
at 59 U.S. exam sites (including satellites and remote sites). Women were not eligible if they
had medical conditions predictive of survival time less than three years, if they were known to
have conditions inconsistent with study participation and adherence (e.g. alcohol dependence),
or if they were active participants in another randomized controlled trial. Women also were
ineligible for reasons of competing risk and safety (e.g. acute myocardial infarction in the last
6 months or severe hypertension). Each intervention arm also incorporated specific eligibility
criteria. Those who remained eligible and interested were invited to follow-up visits at 3, 6 and
9 years. Rigorous quality assurance programs were in place through close-out (September,
2004 - March, 2005). From the entire WHI clinical trials population (N=68,133), the first-
recorded, resting 12-lead ECG of participants examined during 1999-2004 (N=58,705) were
included. Those who were using an anti-arrhythmic medication, defined as prescribed Type I,
I-A, I-B, I-C, III or miscellaneous anti-arrhythmic medications, at the time of ECG recording
or whose ECG was of such poor quality as to prevent accurate measurement of ectopy
(N=1,283) were also excluded. The effective sample size for this study is 57,422.
Electrocardiograms (ECG)
Centrally trained and officially certified technicians recorded standard, twelve-lead ECG at
baseline and each follow-up visit (WHI Study Group 1994). They placed disposable Ag/AgCl
electrodes on the precordium relative to standard anatomical landmarks using the E-V6
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Halfpoint Method (Rautaharju et al.1976), a HeartSquare (NovaHeart, Inc), and strictly
standardized protocols for positioning chest electrodes in women (Rautaharju et al. 1998). They
digitally recorded ECG with participants in the resting, supine position using MAC PC
electrocardiographs (GE Marquette, Inc). Upon successful recording, they transmitted ECG
by telephone modem to the Epidemiological Cardiology Research (EPICARE) Center for
visual inspection, error / missing lead detection, quality grading, and electronic reading by the
Marquette 12SL program (GE Marquette, Inc).
Ectopy identification and classification
VE and SVE beats were detected both by computer algorithms of the Minnesota code (MC)
together with visual over-reads of every WHI ECG transmitted to EPICARE for “flagging” of
arrhythmias. The presence or absence of either VE or SVE beats (Minnesota Codes 8.1.1 or
8.1.2) (Prineas et al. 1982) in each 10-sec recording was entered into a separate database
prepared for the WHI Clinical Coordinating Center for this study. In this non-patient
population, few participants had more than one VE or SVE beat in their 10-sec ECG. Therefore,
outcomes were analyzed as binary variables: presence vs. absence of ectopy. For comparison,
VE and SVE were also combined into a single binary outcome (any ectopy).
Addresses and Geocodes
Participant addresses were collected at each visit and updated at least biannually. All of the
participant and clinical center addresses in the contiguous U.S. from baseline through follow-
up were cleaned according to a standardized protocol. These addresses were submitted in bloc
to a single geocoding vendor selected from 4 candidates on the basis of its accuracy (Whitsel
et al. 2004; 2006). The vendor assigned coordinates (latitudes; longitudes) and unique census
identifiers (U.S. Census 2000 Federal Information Processing Standards [FIPS] codes) to >
99% of the addresses. Of these addresses, 91% were street-type matches.
Air Pollutant Concentrations
All ambient criteria air pollutant concentration data recorded at monitors operating in the
contiguous U.S. during the study period (1999-2004) were obtained from the U.S.
Environmental Protection Agency Air Quality System (U.S. EPA AQS 2006). The data
included the longitude and latitude of each monitor. The data were cleaned and then used to
fit national scale, log-normal kriging with a spherical model for spatial interpolations to
produce geocoded location-specific daily mean concentrations of PM2.5 and PM10. From these
daily concentration data, the daily concentrations of PM2.5 and PM10 were calculated for each
participant and exam site 0-365 days prior to the ECG measurements (Lag0-365) (Liao et al,
2006, 2007). The primary focus of this study is on the acute (Lag0 to Lag2), subacute
(Lag1-30, calculated as 30-day average concentrations before the ECG), with secondary focus
on the long-term chronic PM exposures (Lag1-365, calculated as 365-day average
concentrations before the ECG).
Weather Variables
All meteorological data recorded at stations operating in the contiguous U.S. during the study
period were obtained from the National Climatic Data Center (U.S. NCDC). Data included
ambient temperature and pressures, as well as station longitudes, latitudes, and altitudes. Data
were cleaned and missing sea level pressures were replaced with values computed from station
and altimeter pressures using the station altitude, ambient temperature, and U.S. Standard
Atmosphere temperature profile (U.S. COESA 1976). For stations with ≤ 6 consecutive hr
(25%) of data on temperature and sea level pressure, the station-specific daily mean
temperature and sea level pressure were imputed from nearby stations. Finally, daily mean
temperature (°C) and pressure (kPa) at each geocoded address from baseline to closeout were
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calculated by averaging these daily means across all stations within 50 km, a distance over
which their station-to-station correlations exceed 0.9 (Ito et al. 2005). In 2000, for example,
such calculations were based on an average across 4.2 stations. To the 2% of addresses ≥ 50
km (on average, 63 km) away from the nearest temperature station, the daily mean of that
station was assigned. Thereafter, acute, subacute, and chronic meteorological exposure
measures were calculated for each participant as described above.
Other Participant-Level Characteristics
Self-reported socioeconomic characteristics (education; total family income in the preceding
year), health history (see below) and a variety of other attributes were determined at each visit
by standardized participant interview and examination. Interim health events also were
identified via standardized medical record review and physician adjudication. Medications
taken at least twice per week for the two-week period before the ECG recording were
therapeutically classified according to the Medispan Master Drug Database (MDDB). Anti-
arrhythmic medications specifically included those with Type I, I-A, I-B, I-C, III or
miscellaneous anti-arrhythmic activity. The definition for anti-arrhythmic medication
excluded the beta-antagonists (i.e. β-blockers), diuretics, and cardiac glycosides (e.g. digitalis).
These latter categories were included in the study’s definitions of hypertension and congestive
heart failure, respectively. Diabetes was defined by anti-diabetic medication use or history;
hypertension by anti-hypertensive medication use, systolic blood pressure ≥ 140 mmHg, or
diastolic blood pressure ≥ 90mm Hg, or history; body mass index as the ratio of weight to
height squared (BMI, kg/m2); smoking as current, former, or never; chronic lung disease by
history of asthma, emphysema or lung cancer; coronary heart disease (CHD) by anti-anginal
medication use, history of angina or myocardial infarction and medical record review /
adjudication; revascularization by history of coronary artery angioplasty, stent or bypass and
medical record review / adjudication; and congestive heart failure (CHF) by cardiac glycoside /
diuretic use, history and medical record review / adjudication.
Statistical Analysis
All analyses were conducted among the effective sample of 57,422 participants. A three-stage
analysis was performed. The first two stages were performed using SAS Version 9.01, and the
third stage using Stata Version 9.0. At the first stage, logistic regression models were used that
allowed PM effects to vary randomly across exam sites to test, individually, the a priori
hypothesized interactions between PM exposures and current smoking status, age, ethnicity,
treatment arm, history of CVD (i.e. CHD, stroke, hypertension, or diabetes), and chronic lung
disease. Our objective here was to identify any potential PM effect modifiers. The second and
third stage forms traditional “two-stage random-effects models”. Specifically, at the second
stage, center-specific, individual-level covariable-adjusted logistic regression analysis was
performed to obtain center-specific PM regression coefficients and their corresponding
standard errors (SE). At this stage, if an effect modifier was identified in first stage of analysis
(e.g., smoking), then, a center-specific multivariable logistic regression was performed to
obtain PM regression coefficients (SE) for each level of the effect modifier. At the third stage,
the random-effects meta-analysis model was performed, averaging across the inverse-variance-
weighted, center-specific regression coefficients, to obtain pooled odds ratios and their 95%
CI at each level of the effect modifier (Berkey et al., 2005). The OR) and their 95% CI are
therefore center-variance weighted overall estimates of the association between PM exposures
and the occurrence of ectopy on the 12-lead ECG. In addition to reporting the results by effect
modifier status, the overall OR for all participants was also presented. The effect modifier was
treated as a covariate in the second stage of the multivariate logistic regression analysis as
mentioned above. As a result, each center only had one regression coefficient, which was then
pooled together in meta-analysis to yield the final OR for the entire cohort. All results are
expressed as per 10 μg/m3 increase in PM10 or PM2.5.
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The demographic and cardiovascular disease risk profiles of the study population are presented
in Table 1. The mean age at the time of ECG recording was 67.5 years, with 84% non-Hispanic
white. The proportion of participants who reported being current cigarette smokers was only
about 6%, which is lower than the national average. Other levels of cardiovascular disease risk
factors / co-morbidity in this population were similar to that of national samples. Overall, the
prevalence of 12-lead ECG detected VE, SVE, and both ectopy was 1.68%, 2.88%, and 0.12%,
respectively, resulting in any ectopy rate of 4.68%. Both estimated PM2.5 and PM10 in this
study population were normally distributed, with the inter-quartile values close to 2-times the
standard deviations of PM2.5 and PM10.
Of the interactions examined at the first stage, only acute PM2.5 and PM10 interactions with
current smoking status were significant when VE was the outcome of interest. Subsequent
analyses of VE were therefore stratified by current smoking status. At the second stage, the
center-specific PM-VE regression coefficients (SE) were adjusted for age, race, center,
education, history of CVD and chronic lung disease, relative humidity, temperature and 365-
day average PM concentration. Those for SVE and any ectopy also were adjusted for current
smoking. Results of the random-effects meta-regression analysis of these center-specific
regression coefficients (SE) are presented in Table 2. In summary, among current smokers,
Lag0 and Lag1 PM concentrations were significantly associated VE. For example, the OR (95%
CI) for VE among current smokers was 2 (1.32-3.3) at Lag1 PM2.5 and 1.32 (1.07-1.65) at
Lag1 PM10, respectively. For non-current smokers, the OR (95% CI) was 1.05 (0.94-1.17) and
1.01 (0.94-1.07), respectively. The Lag2 concentrations also were associated with VE, but the
associations were not significant. Acute PM exposures were not significantly associated with
SVE. Additional adjusting treatment arm, day-of-week, and seasonal indicator variables did
not change the pattern of association (data not shown).
PM as subacute exposure (Lag30), as well as chronic exposure (Lag365), was also analyzed and
none of them was significantly associated with ectopy (data not shown). It may be possible
that the lack of association with subacute and chronic exposures may be explained by the lower
variation in the longer-term exposure levels, especially between participants within centers.
As a sensitivity analysis, Lag0, Lag1, and Lag2 were also forced together in to one model, and
the pattern of associations with both VE and SVE was similar to that presented in Table 2 (data
not shown). It is worth noting that our GIS-based PM estimates relied solely on the measured
PM concentrations near the geocoded participants’ addresses. As such, for some very remote
locations on the days when no nearby air quality monitors reported PM concentration data, the
errors of estimated PM, judged from the prediction error from the kriging model, tended to be
larger. This was especially the case when there were no measured PM data within a 100 mile
radius of a geocoded address. Sensitivity analysis was thus performed by excluding participants
from the final models when their Lag0 PM prediction errors were greater than two times their
estimated PM concentrations. As anticipated, such an approach yielded similar OR, with
narrower 95% CI (data not shown). The OR and their 95% CI reported here are based on the
more inclusive, but also more conservative, models.
Discussion
A large number of epidemiologic studies showed an association between short-term exposure
to increased particulate air pollution and CVD morbidity and mortality (Brook et al. 2004;
Craig et al. 2008). However, the mechanisms responsible for such an association have not been
fully identified. Previous studies suggested several promising underlying mechanisms,
including cardiac autonomic impairment as measured by lower heart rate variability (Creason
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et al. 2001; Gold et al. 2000, Liao et al. 1999, 2004; Pope et al. 1999). Other studies indicated
that impaired cardiac autonomic control may lower the threshold for arrhythmia (Huikuri et
al. 2001), and that ECG-detected ectopy, especially that of ventricular origin, may predict
cardiovascular disease mortality (Engel et al, 2007; Rautaharju et al, 2006a). Because many
publications repeatedly reported an association between acute PM exposure and lower HRV,
it was postulated that an acute increase in ambient PM concentration may imbalance
sympathetic and parasympathetic nervous control of the heart and thereby decrease threshold
for ectopy. Through such PM-mediated decreases, short-term acute PM exposure may thereby
trigger the onset of clinical cardiac events. In our study, data on the PM exposures, the HRV
measures, and ectopy measures were presented. However, since ectopy is an exclusion criterion
for our HRV measures, it was not possible to assess this hypothesis directly in this population.
Instead, the associations of PM exposure with ectopy (this paper) and HRV (to be published
else where), were assessed, respectively.
Among the post-menopausal women participating in the WHI clinical trials, a significant, direct
association was found between acute exposure to ambient PM2.5 and PM10 and ventricular
ectopy among current smokers that gives some credence to this hypothesis. This study,
however, did not find significant associations between acute PM exposure and ventricular
ectopy among non-smokers, acute PM exposure and supaventricular ectopy, or chronic PM
exposure and ectopy.
This is the first study to demonstrate such an association in a large, non-patient, geographically
diverse, female population not selected on the basis of having an ICD (Table 3). The study
thereby broadens the scope of the extant literature in the area, which to date, has been based
on a handful of small, overlapping, single-city studies of majority-male, patient populations
with ICD or Holter ECG assessed potential role of ventricular arrhythmogenesis in PM-
mediated cardiovascular risk (Peters et al 2000;Rich et al. 2004;2005;2006;Vedal et al.
2004;Dockery et al. 2005a;2005b;Ebelt et al. 2005;Berger et al. 2006;Sarnat et al.
2006;Metzger et al. 2007). Our findings are nonetheless consistent with those previously
described in several of these populations, although as a group, the WHI CT participants were
clearly much less vulnerable to ventricular tachyarrhythmia than those in Table 3. If our
findings are confirmed by others, the confirmation would provide support for the hypothesized
role of autonomic imbalance and ventricular arrhythmogenesis in PM-mediated cardiovascular
risk.
It should be noted that this study has several limitations that may affect interpretation of its
findings. First, it is an ancillary study of participants in the WHI clinical trial. As such, women
in it were randomized to estrogen ± progestin treatment, calcium / vitamin D supplementation,
and / or dietary modification. Although randomized, these exposures may have affected
measures of both ectopy and smoking status. However, it is of interest that adjustment of
treatment arm did not change the pattern of association in our data. Similarly, the participants
selected to participate in the WHI clinical trials may not be representative of the general female
population. This is evidenced by lower current smoking rate in this population (6%) as
compared to the US female population (about 18%).
Second, ectopy was measured from resting, standard 12-lead ECG which were only 10 sec in
duration. The presence and temporal distribution of ectopy are highly variable and dependent
on circadian rhythms, physical activity, as well as on other environmental and clinical
conditions. Clinically, the standard duration used to evaluate ectopy is 24 hr, which was not
feasible in this large-scale, population-based study. However, it is important to note that a
standard 12-lead ECG only captures an extremely small window of cardiac rhythm, and is
insensitive for detecting ectopy among relatively healthy populations especially when its
frequency is low or varies diurnally. Despite such insensitivity, it has been argued that when
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the purpose is to identify participants at risk with relatively high specificity, short ECG
recordings serve this epidemiologic objective reliably. Indeed, ectopy frequent enough to be
captured by short recordings may carry more prognostic significance than ectopy infrequent
enough to require long recordings to capture it (Abdalla et al. 1987; Evenson et al. 2000;
Ruberman et al. 1981;1981b). The insensitivity of the ECG may have nevertheless biased the
observed association between acute PM exposure and ventricular ectopy towards the null. It
is also possible that the frequency of ectopy among smokers is higher than that among non-
smokers, which may lead to even lower sensitivity of detection among non-smokers. This may
help explain why an association between PM and ectopy among non-smokers was not found.
Third, PM10 was not directly measured in the personal breathing space of participants. Instead,
it was spatially interpolated at each participant’s geocoded address, raising questions about its
validity as a surrogate of personal exposure or biological exposure. To overcome this particular
limitation, the reliability and accuracy of address geocoding (Whitsel 2004;2006), and spatial
interpolations (Liao et al. 2006;2007) was carefully established. The advantages of our spatial
correlation based PM estimation over traditional area averages was previously discussed (Liao
et al. 2006). Finally, data on the chemical components of the ambient particles were not
available. Therefore, one can only implicate the involvement of both PM10 and PM2.5
concentrations, but can not elucidate the specific chemical components responsible for their
adverse effects.
In this study, a significant effect modification by current smoking status in the acute PM
exposure-ventricular ectopy relationship was shown. Our finding is consistent with that from
the American Cancer Society-Cancer Prevention II (ACS-CPII) study, which also found that
PM exposures were more strongly associated with mortality from dysrhythmias and cardiac
arrest among current than former or never smokers (Pope et al. 2004). Such effect modification
is biologically relevant, for several reasons. It is well-known that smoking increases
vulnerability to various adverse health conditions, as illustrated by e.g. ACS-CPII. Our data
are suggestive of a higher vulnerability to PM effects among smokers. It is also likely that
current smoking is related to higher frequency of ectopy, and by extension, higher chance of
detection by the standard 12-lead ECG. These arguments provide plausible explanations as to
why observed associations between acute PM exposures and ventricular ectopy in non-smokers
lacked significance in this context, if not others.
The present data show that the subacute exposures (Lag30) and chronic exposures (Lag365) are
not significantly associated with ectopy. Moreover, when simultaneously controlled for
subacute and chronic exposures into the analyses, the association between acute exposures
(Lag0; Lag1; Lag2) and ectopy remained similar. Such a lack of chronic effects, similar to our
previous findings (Liao et al. 2006; 1999), support our hypothesis that PM effects on cardiac
autonomic control are in general acute. Studies are needed to examine the actual time course
of PM effects.
Finally, multiple statistical models were utilized in our analyses. Given the biological
plausibility, our a priori hypothesized short-term acute effect (e.g. Lag0 and Lag1 effects), data
were not adjusted for multiple testing in our main findings. As such, it was not possible to fully
exclude the possibility of significant findings by chance. However, it is very unlikely that “the
chance findings” just occurred among those to be most vulnerable and on the exposure windows
that are believed to be the most important time period for PM action. For the interested readers,
Bonferroni correction was performed on OR of PM2.5 effect on ventricular ectopy among
current smokers (OR=2, 95% CI 1.32, 3.03, Table 2). After correction for 30 tests performed
in Table 2, the Bonferroni-corrected OR remained significant (OR=1.36, 95% 1.03 to 3.89).
It can be argued that this application of Bonferroni correction is over-conservative; that is,
variuos studies showed that PM exerted more adverse health effects at lag1 and lag0 than at
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other lags. Therefore, the number of tests need to be adjusted for need to be smaller than 30
used in the above example. For all of the above reasons it was decided to present the main
results without adjusting for multiple testing.
In summary, acute exposure to ambient PM2.5 and PM10 is directly associated with higher odds
of ventricular ectopy among smokers, suggesting that they are more vulnerable to the
arrhythmogenic effects of PM. These and other published data support the proposed role of
autonomic imbalance and ventricular arrhythmogenesis in PM-mediated cardiovascular risk.
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Table 1
The demographic and cardiovascular disease risk profiles (mean [SD] or proportion) of the study population on the
date of ECG examination
ALL (N=57,422) Any EctopyNO (N=54,732) YES (N=2,690)
Age at ECG date (years) 67.5 (6.9) 67.3 (6.8) 70.5 (6.8)
Race ( %, White) 83.52 83.47 84.57
Education (%, <= HS) 24.05 24.02 24.54
Current smoking (%) 5.85 5.83 6.31
Diabetes (%) 8.63 8.55 10.30
Hypertension (%) 51.97 51.57 60.15
Chronic lung disease (%) 10.33 10.25 11.86
CHD (%) 7.59 7.46 10.30
Ventricular ectopy (%) 1.68 -- --
Supraventricular ectopy (%) 2.88 -- --
Lag1 PM2.5 (μg/m3)
      - Mean (SD) 13.8 (7.9) 13.8 (7.9) 13.8 (7.6)
      - 5th / 95th Percentile 5 / 29.1 5 / 29.2 5.06 / 28.5
Lag1 PM10 (μg/m3)
      - Mean (SD) 27.5 (12.1) 27.5 (12.1) 27.5 (11.9)
      - 5th / 95th Percentile 12.2 / 48.9 12.3 / 48.8 11.8 / 49.3
Lag-1 relative humidity (%) 68 (15) 68 (15) 67 (16)
Lag-1 temperature (°C) 13.9 (9.1) 13.9 (9.1) 14 (8.7)
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